Stay updated on Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial page.

Latest updates to the Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-status notice and the previous Revision: v3.4.1 banner.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the revision to v3.4.1 (removing v3.4.0).SummaryDifference0.2%

- Check28 days agoChange DetectedShow glossary is now available, and the label for QC updates has been updated to 'Last Update Submitted that Met QC Criteria'. The page now includes a 'No FEAR Act Data' notice and shows the site revision as 'Revision: v3.4.0' (replacing 'v3.3.4').SummaryDifference0.1%

- Check64 days agoChange DetectedLocations section reorganized under a single Locations heading, adding a comprehensive list of study sites across multiple regions. Individual location headings were removed and replaced with the consolidated locations list.SummaryDifference2%

- Check85 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2 with no substantive changes to the page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check93 days agoChange DetectedThe Publications section was updated to rephrase that publications are provided voluntarily by the person who enters information about the study and are about the results of the study, and the revision note changed from v3.2.0 to v3.3.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amcenestrant vs Physician's Choice in ER+ Breast Cancer Clinical Trial page.